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Carbazoles, an important class of indole alkaloids has gained much importance in
recent years due to their diverse biological activities (1–4). The therapeutic prominence
of the carbazole derivatives was well established (4–6). Also, pyridocarbazoles were re-
ported to elicit anticancer (4–10) and anti-HIV properties (11) and hence they have
gained an important place in medicinal chemistry (12). The discovery of the antineoplastic
activity of the naturally occurring alkaloid ellipticine and its isomer olivacine have stimulated
considerable research efforts in the field of condensed systems (13). A variety of carbazoles
and pyrido-annelated carbazoles represent DNA ligands with pronounced antitumor ac-
tivity (14). Moreover, azines such as naloxone and naltrexone have shown an ultra-long
lasting antagonistic activity for the opioid  receptor sub type (15). With the aim to con-
struct such condensed systems with the carbazole nucleus, we turned our attention to
synthesizing 1-hydrazinocarbazoles that would be an important synthon for the synthe-
sis of fused heterocycles.
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Reaction of 1-oxo-1,2,3,4-tetrahydrocarbazoles 1a-e with
hydrazine hydrate in absolute ethanol afforded N,N-bis-
-carbazolylazine derivatives 2a-e. Treatment of compounds
1a-e with hydroxylamine hydrochloride in ethanol with
a catalytic amount of pyridine resulted in the formation
of 1-hydroxyimino-1,2,3,4-tetrahydrocarbazoles 3a-e. Re-
duction of 3 with hydrazine hydrate in the presence of
palladized carbon afforded N,N-carbazolyl hydrazine
derivatives 4a-e. The newly formed compounds were
characterized by IR, 1H NMR, mass spectra and by ele-
mental analysis. All compounds proved to have great
potentialities as antibacterial and antifungal agents due
to the presence of the azine or the hydrazine group. Par-
ticularly, the chloro substituted derivatives 2e and 4e
showed excellent antibacterial and antifungal activity.
Keywords: 1-oxo-1,2,3,4-tetrahydrocarbazoles, 1-hydroxy-
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EXPERIMENTAL
Melting points were determined using a Mettler FP 51 apparatus (Mettler Instru-
ments, Switzerland) and were uncorrected. IR spectra were recorded on a Shimadzu
FTIR-8201 PC spectrophotometer (Shimadzu, Japan) using potassium bromide. 1H NMR
spectra were recorded in CDCl3 on a Varian AMX 400 FT-NMR spectrometer (Varian
Australia, Australia) using tetramethylsilane as internal standard. Mass spectra were re-
corded on a Jeol-JMS-D-300 mass spectrometer (70 eV) (Jeol, Japan). Microanalyses were
done on a Perkin Elmer Model 240 CHN analyzer (Perkin-Elmer, USA). The purity of
the products was tested by TLC using glass plates coated with silica gel G (HiMedia
Laboratories, India) and petroleum ether and ethyl acetate as developing solvents.
Synthesis of N,N-bis(1,2,3,4-tetrahydrocarbazol-1-yl)azine (2a-e). General method
A mixture of 1-oxo-1,2,3,4-tetrahydrocarbazole (1a-e, 0.001 mol) and hydrazine hy-
drate (1 mL, 0.02 mol) in absolute ethanol (20 mL) was heated under reflux for 5 h. The
solvent was evaporated under reduced pressure and the residue obtained was poured
into ice cold water and extracted with ethyl acetate. The organic layer was thoroughly
washed with water and then dried over anhydrous sodium sulphate. Thus obtained
crude product was recrystallized from petroleum ether/ethyl acetate 95:5 mixture to
yield N,N-bis(1,2,3,4-tetrahydrocarbazol-1-yl)azines (2a-e) as yellow crystalline pow-
ders (Tables I and II).
Synthesis of N,N-(carbazol-1-yl-1,2,3,4-tetrahydrocarbazol-1-yl)-
-hydrazine (4a-e). General method
The appropriate 1-hydroxyimino-1,2,3,4-tetrahydrocarbazole (3, 0.001 mol) was dis-
solved in 20 mL of absolute ethanol and 100 mg of palladized carbon (10%) was added.
To this mixture, maintained in an ice bath, 2 mL (0.04 mol) of hydrazine hydrate was
added. The reaction mixture was refluxed for 5 h. The reaction mixture was filtered and
the solvent was distilled under reduced pressure. The crude mixture obtained was ex-
tracted with ethyl acetate, washed with water and dried over anhydrous sodium sul-
phate. Removal of the solvent followed by crystallization from petroleum ether/ethyl
acetate mixture (98:2) yielded N,N-(carbazol-1-yl-1,2,3,4-tetrahydrocarbazol-1-yl)-hy-
drazines 4 (Tables I and II).
Antimicrobial studies
Antibacterial activity. – All the newly synthesized compounds (2a-e and 4a-e) were
screened for their in vitro antibacterial activity against Escherichia coli (ATCC 10536),
Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 9027) and Bacillus
subtilis (ATCC 6633) according to the disc diffusion method (19). The minimal inhibitory
concentration (MIC) was determined by the serial dilution technique using chloroform
as a solvent. Furacin was used as a standard drug in antibacterial screening studies. The
results are presented in Table III.
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Antifungal activity. – The antifungal screening studies of compounds 2a-e and 4a-e
were performed by the standard agar disc diffusion method (20). Seven days old cul-
tures of Aspergillus niger (ATCC 16404), Candida albicans (ATCC 10231), Altenaria macro-
spora and Fusarium oxysporum (isolated from rotten fruits) were used as test organisms.
They were grown on a potato dextrose agar medium. The MIC values were determined
by the serial dilution technique using chloroform as a solvent. The growth of the micro-
organisms was determined visually and the lowest concentration that inhibited the
growth of the microorganisms for 24 hours at 37 C was taken as the MIC. The standard
drug used for comparison in antifungal screening studies was clotrimazole. The results
are presented in Table IV.
Solutions of the standards, furacin and clotrimazole, were prepared in chloroform.
A control experiment with chloroform alone was also done for both the antibacterial and
antifungal activity studies.
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Table I. Physical characterization of N,N-bis(1,2,3,4-tetrahydrocarbazol-1-yl)azine derivatives (2a-e)
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2.10–2.21 (m, 4H, C3-2H, C3-2H), 2.54 (s, 6H, C8-CH3 and
C8-CH3), 2.83–3.10 (m, 8H, C2-2H, C4-2H, C2-2H, C4-2H),
7.03–7.64 (m, 6H, C5-H to C7-H and C5-H to C7-H), 8.51 (b






2.06–2.10 (m, 4H, C3-2H, C3-2H), 2.47 (s, 6H, C7-CH3 and
C7-CH3), 2.86–3.18 (m, 8H, C2-2H, C4-2H, C2-2H, C4-2H),
6.80–7.46 (m, 6H, C5-H, C6-H, C8-H and C5-H, C6-H, C8-






2.05–2.11 (m, 4H, C3-2H, C3-2H), 2.45 (s, 6H, C6-CH3 and
C6-CH3), 2.82–3.02 (m, 8H, C2-2H, C4-2H, C2-2H, C4-2H),
7.07–7.39 (m, 6H, C5-H, C7-H, C8-H and C5-H, C7-H, C8-






2.00–3.06 (m, 12H, C2-2H, C3-2H, C4-2H, C2-2H, C3-2H, C4-
2H), 7.06–7.64 (m, 8H, C5-H, C6-H, C7-H, C8-H, C5-H,







2.06–2.12 (m, 4H, C3-2H, C3-2H), 2.52–2.99 (m, 8H, C2-2H,
C4-2H, C2-2H, C4-2H), 7.11–7.56 (m, 6H, C5-H, C7-H, C8-H




3494, 3396, 3294 (NH)
1137 (N-N)
2.01–2.18 (m, 4H, C2-2H, C4-2H), 2.49 (s, 3H, C8-CH3), 2.57
(s, 3H, C8-CH3), 2.78–3.00 (m, 3H, C1-H, C3-2H), 6.92–7.50
(m, 9H, C2-H to C7-H and C5-H to C7-H), 10.80 (b s, 1H,
carbazole-N9H), 10.90 (b s, 1H, carbazole-N9H), 11.45 (b s,
1H, C1-NH), 11.51 (b s, 1H, C1-NH)
394
4b
3450, 3385, 3251 (NH)
1132 (N-N)
2.47 (s, 3H, C7-CH3), 2.50 (s, 3H, C7-CH3), 2.63–3.19 (m, 7H,
C1-H, C2-2H, C3-2H, C4-2H), 6.81–7.51 (m, 9H, C2-H to
C6-H, C8-H and C5-H, C6-H, C8-H), 8.77 (b s, 1H, carbazole-
N9H), 8.99 (b s, 1H, carbazole-N9H), 9.92 (b s, 1H, C1-NH),
9.97 (b s, 1H, C1-NH)
394
4c
3464, 3350, 3271 (NH)
1134 (N-N)
2.37 (s, 3H, C6-CH3), 2.40 (s, 3H, C6-CH3), 2.48–2.97 (m, 7H,
C1-H, C2-2H, C3-2H, C4-2H), 6.99–7.43 (m, 9H, C2-H to
C5-H, C7-H, C8-H and C5-H, C7-H, C8-H), 11.03 (b s, 2H,
carbazole-N9H and carbazole-N9H), 11.43 (b s, 1H,
C1-NH), 11.71 (b s, 1H, C1-NH)
394
4d
3454, 3414, 3310 (NH)
1124 (N-N)
2.07–3.06 (m, 7H, C1-H, C2-2H, C3-H, C4-2H), 7.10–7.62
(m, 11H, C2-H to C8-H and C5-H to C8-H), 8.85 (b s, 1H,
carbazole-N9H), 9.04 (b s, 1H, carbazole-N9H), 10.07 (b s,
2H, C1-NH and C1-NH)
366
4e
3424, 3390, 3255 (NH)
1127 (N-N)
2.08–3.00 (m, 7H, C1-H, C2-2H, C3-H, C4-2H), 6.98–7.66
(m, 9H, C2-H to C5-H, C7-H, C8-H and C5-H, C7-H, C8-H),
10.96 (b s, 1H, carbazole-N9H), 11.17 (b s, 1H, carbazole-
N9H), 11.85 (b s, 2H, C1-NH and C1-NH)
435
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Table III. Antibacterial activity of N,N-biscarbazolylazine (2a-e) and












2a 100.0 150.0 150.0 12.5
2b 200.0 50.0 50.0 100.0
2c 50.0 25.0 50.0 12.5
2d 100.0 50.0 100.0 200.0
2e 6.0 12.5 25.0 12.5
4a 200.0 50.0 25.0 100.0
4b 100.0 75.0 50.0 100.0
4c 12.5 25.0 50.0 100.0
4d 200.0 100.0 100.0 50.0
4e 6.0 12.5 50.0 12.5
Furacin (standard) 6.0 12.5 12.5 12.5
a CHCl3 solvent – negative control
Table IV. Antifungal screening data of N,N-biscarbazolylazine (2a-e)












2a 100 12.5 100 200
2b 100 100 100 150
2c 25 25 100 25
2d 100 200 200 100
2e 25 12.5 50 50
4a 50 12.5 100 200
4b 200 100 100 200
4c 25 100 50 25
4d 100 200 100 100
4e 25 12.5 50 25
Clotrimazole
(standard)
25 12.5 25 25
a CHCl3 solvent – negative control
RESULTS AND DISCUSSION
From the aforesaid facts, the reaction of 1-oxo-1,2,3,4-tetrahydrocarbazoles (1a-e) (16)
with hydrazine hydrate was performed in order to synthesize 1-hydrazinocarbazoles (5).
However, the reaction afforded the dimerized N,N-biscarbazolylazines 2a-e. Failing to
achieve our targeted 1-hydrazinocarbazoles (5), an another attempt was made to reduce
1-hydroxyimino-1,2,3,4-tetrahydrocarbazoles 3 (17, 18) with palladium on 10% carbon in
the presence of hydrazine hydrate to obtain 1-aminocarbazoles (6), which also failed. The
product was again a dimerized product and it was found to be N,N-(carbazol-1-yl-
-1,2,3,4-tetrahydrocarbazol-1-yl)hydrazine (4a-e). Thus obtained dimerized carbazole
derivatives were tested for their in vitro antibacterial and antifungal activity. Some of the
compounds have shown significant activities against all the tested bacteria and fungi.
In the present investigation, 8-methyl-1-oxo-1,2,3,4-tetrahydrocarbazole (1a) was
treated with hydrazine hydrate (99%) in absolute ethanol at 90 C for 5 h to afford a new
product (2a). Its IR spectrum showed bands corresponding to the NH group at 3464 and
3310 cm–1. Strong bands in the region 1601 and 1588 cm–1 were due to C=N. The N-N
stretching vibration was inferred from a less intense band at 1122 cm–1. Its 1H NMR
spectrum showed the presence of two methyl groups by a singlet with six-proton inten-
sity at  2.54 ppm. The appearance of a multiplet in the region  2.10–2.21 ppm due to
the C3 and C3 methylene protons and another multiplet between  2.83–3.10 ppm due to
the C2, C4, C2 and C4 methylene protons suggest the formation of 2a instead of com-
pound 5a. The aromatic protons at C5, C6, C7 and C5 to C7 resonated as a multiplet of
six-proton intensity at  7.03–7.64 ppm. The carbazole NH protons at N9 and N9 ap-
peared as two broad singlets at  8.51 ppm and  8.58 ppm, respectively. The mass spec-
trum showed the molecular ion (m/z) peak at 394 (100%) with major fragmentation
peaks at 379 (11.5%), 365 (7.1%), 337 (11.4%), 323 (5.2%), 262 (5.8%) and 198 (22.2%). The
elemental analysis agreed well with the molecular formula C26H26N4. The spectral data
and the elemental analysis have proved the formation of a dimerized carbazole deriva-
tive, viz., N,N-bis(8-methyl-1,2,3,4-tetrahydrocarbazol-1-yl)azine (2a). The series of com-
pounds 2b-e was prepared by repeating the analogous experiment from 1b, 1c, 1d and
1e, respectively (Scheme 1).
The formation of N,N-bis(1,2,3,4-tetrahydrocarbazole-1-yl)azine (2) instead of 1-hydra-
zinocarbazole (5) from 1-oxo-1,2,3,4-tetrahydrocarbazole (1) in the reaction with hydrazine
hydrate could be explained as follows. In the proposed mechanism it is reasonable to as-
sume that 1-oxo-1,2,3,4-tetrahydrocarbazole (1) forms hydrazone A, which further reacts
with 1 to yield 2. However, our attempt to isolate hydrazone A was unsuccessful. It was
supposed to be the in situ condensation of A with 1, which resulted in the formation of 2
(Scheme 2).
The reduction of 3 with hydrazine hydrate in the presence of palladium on 10% car-
bon yielded a dimerized product, namely, N,N-(carbazol-1-yl-1,2,3,4-tetrahydrocarba-
zol-1-yl)hydrazine (4) instead of 1-aminocarbazole 6. In this regard, the reduction of
8-methyl-1-hydroxyimino-1,2,3,4-tetrahydrocarbazole (3a) with hydrazine hydrate in
the presence of palladium on 10% carbon afforded a new product. The IR spectrum of
the compound showed intense bands at 3494, 3396 and 3294 cm–1 for NH stretching vi-
brations. A weak band at 1137 cm–1 was due to the N-N stretching vibration. The 1H
NMR spectrum revealed the presence of two methyl groups (C8-CH3 and C8-CH3) by
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two singlets at  2.49 ppm and  2.57 ppm. The methylene protons at C2 and C4 reso-
nated as a multiplet at  2.01–2.18 ppm. The methylene protons at C1-H and C3-2H ap-
peared as a multiplet between  2.78–3.00 ppm. The aromatic protons at C2 to C7 and C5
to C7 resonated as a multiplet between  6.92–7.50 ppm. The carbazole NH protons at
N9 and N9 showed two broad singlets at  10.80 ppm and at  10.90 ppm, respectively.
The two broad singlets at  11.45 ppm and at  11.51 ppm were due to the C1-NH and
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a R1 = R1' = R2 = R2' = H, R3 = R3' = CH3
b R1 = R1' = R3 = R3' = H, R2 = R2' = CH3
c R2 = R2' = R3 = R3' = H, R1 = R1' = CH3
d R1 = R1' = R2 = R2' = R3 = R3' = H
















































C1-NH protons, respectively. The intensity of the peaks present in the aliphatic and aro-
matic region in the 1H NMR spectrum has clearly revealed that only a part of the prod-
uct was aromatized and differed from compound 2a. The mass spectra showed the mo-
lecular ion peak at m/z 394 (100%) with fragmentation peaks at 380 (48%), 366 (18.8%),
351 (5.8%), 337 (4.5%), 323 (3.3%), 224 (15%) and 199 (68%). The elemental analysis agreed
well with the molecular formula C26H26N4. From the spectral and elemental data, the
structure of the product was found to be N,N-8,8-dimethyl-(carbazol-1-yl-1,2,3,4-
tetrahydrocarbazol-1-yl)-hydrazine (4a). The repeatability of the experiment was tested
on 3b, 3c, 3d and 3e to afford 4b, 4c, 4d and 4e, respectively (Scheme 1).
The formation of 4 might be as follows. Hydrazine hydrate in the presence of pal-
ladized carbon in ethanol reduced as expected the C=N-OH to the amino derivative to
yield B. On dehydration with C (which was formed in situ from 3 by tautomerization
and areial oxidation) this resulted in the formation of 4. However, our attempts to isolate
compounds B and C were unsuccessful (Scheme 3).
The antibacterial screening studies indicated that the compound having R1 = R1 =
Cl, R2 = R2 = R3 = R3 = H (2e) and R1 = R1 = Cl, R2 = R2 = R3 = R3 = H (4e) showed ex-
cellent antibacterial activity against E. coli, B. subtilis and S. aureus, namely it was as ac-
tive as furacin, but slightly less active against P. aeruginosa (Table III). Among the other
compounds, 2c with the methyl group at C-6 and C-6 showed significant activity against
B. subtilis at 12.5 g mL–1. Moreover, 4c possessed good activity towards E. coli. The ac-
tivity of the other compounds was markedly lower than that of the standard furacin.
The antifungal activity screening studies (Table IV) showed that the chloro substi-
tuted compounds 2e and 4e showed also excellent activity against Aspergillus niger and
Candida albicans with MIC values of 25 and 12.5 g mL–1, respectively, when compared
to the conventional fungicide clotrimazole. Among the other compounds, 2a and 4a ex-
hibited good activity against C. albicans while 2c and 4c were active against F. oxysporum
at concentration of 25 g mL–1. The activities of other compounds were markedly lower
than that of clotrimazole.
Our earlier report (19) indicated that the chloro substituted carbazole derivatives
showed enhanced pharmacological properties. Hence it was supposed that the presence
of either the azine or the hydrazine group along with that of the chloro group might be
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the reason for the enhanced activity of compound 2e or 4e compared to other methyl
substituted compounds. The activity of the compounds was directly proportional to the
concentration of the test solution. The solvent used as the control was found to be inactive
against all the microorganisms chosen for antibacterial and antifungal activity studies.
CONCLUSIONS
A plausible mechanism has been proposed for the synthesis of N,N-bis(1,2,3,4-tetra-
hydrocarbazol-1-yl)azines and N,N-(carbazol-1-yl-1,2,3,4-tetrahydrocarbazol-1-yl)-hy-
drazines. They were tested for their in vitro antibacterial and antifungal activity and the chloro
substituted compounds showed significant activity, comparable with that of both the conven-
tional antibacterial and antifungal standards. Efforts are continuing to alkylate the carbazole ni-
trogen so that the derived compounds may have enhanced pharmacological activity.
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S A @ E T A K
Sinteza i karakterizacija derivata N,N-biskarbazolil azina i N,N-karbazolil
hidrazina i antimikrobni u~inak
ISRAVEL ANTONY DANISH i KARNAM JAYARAMPILLAI RAJENDRA PRASAD
Reakcijom 1-okso-1,2,3,4-tetrahidrokarbazola 1a-e s hidrazin hidratom u apsolutnom
etanolu dobiveni su derivati N,N-biskarbazolilazina 2a-e, a s hidroksilamin hidrokloridom
u etanolu, uz kataliti~ke koli~ine piridina, 1-hidroksiimino-1,2,3,4-tetrahidrokarbazoli 3a-e.
Redukcijom 3 s hidrazin hidratom u prisutnosti paladija na ugljenu nastali su derivati
N,N-karbazolil hidrazina 4a-e. Novosintetizirani spojevi su karakterizirani IR, 1H NMR
i masenom spektroskopijom te elementarnom analizom. Spojevi 2, 3 i 4 su potencijalna
antibakterijska i antimikotska sredstva. Najja~e djelovanje pokazali su derivati 2e i 4e
koji sadr`e klor.
Klju~ne rije~i: 1-okso-1,2,3,4-tetrahidrokarbazoli, 1-hidroksiimino-1,2,3,4-tetrahidrokarbazoli, N,N-bis-
karbazolilazini, N,N-karbazolilhidrazini, antibakterijsko djelovanje, antimikotsko djelovanje
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